These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1736348)

  • 1. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.
    Danielsson A; Löfberg R; Persson T; Salde L; Schiöler R; Suhr O; Willén R
    Scand J Gastroenterol; 1992; 27(1):9-12. PubMed ID: 1736348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis.
    Lindgren S; Löfberg R; Bergholm L; Hellblom M; Carling L; Ung KA; Schiöler R; Unge P; Wallin C; Ström M; Persson T; Suhr OB
    Scand J Gastroenterol; 2002 Jun; 37(6):705-10. PubMed ID: 12126250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
    Hanauer SB; Robinson M; Pruitt R; Lazenby AJ; Persson T; Nilsson LG; Walton-Bowen K; Haskell LP; Levine JG
    Gastroenterology; 1998 Sep; 115(3):525-32. PubMed ID: 9721148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of budesonide enema in patients with distal ulcerative colitis or proctitis.
    Danielsson A; Edsbäcker S; Löfberg R; Nilsson A; Nyman-Pantelidis M; Olsson O; Suhr O; Willén R
    Aliment Pharmacol Ther; 1993 Aug; 7(4):401-7. PubMed ID: 8218754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
    Gross V; Bar-Meir S; Lavy A; Mickisch O; Tulassay Z; Pronai L; Kupcinskas L; Kiudelis G; Pokrotnieks J; Kovács A; Faszczyk M; Razbadauskas A; Margus B; Stolte M; Müller R; Greinwald R;
    Aliment Pharmacol Ther; 2006 Jan; 23(2):303-12. PubMed ID: 16393311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide enema in active haemorrhagic proctitis--a controlled trial against hydrocortisone foam enema.
    Tarpila S; Turunen U; Seppälä K; Aukee S; Pikkarainen P; Elomaa I; Karvonen AL; Kääriäinen I; Sipponen P; Toivanen E
    Aliment Pharmacol Ther; 1994 Dec; 8(6):591-5. PubMed ID: 7696447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.
    Hammond A; Andus T; Gierend M; Ecker KW; Scholmerich J; Herfarth H;
    Hepatogastroenterology; 2004; 51(59):1345-9. PubMed ID: 15362749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
    Rufle W; Frühmorgen P; Huber W; Kimmig JM
    Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
    Löfberg R; Ostergaard Thomsen O; Langholz E; Schiöler R; Danielsson A; Suhr O; Graffner H; Påhlman L; Matzen P; Møller-Petersen JF
    Aliment Pharmacol Ther; 1994 Dec; 8(6):623-9. PubMed ID: 7696452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis.
    Lémann M; Galian A; Rutgeerts P; Van Heuverzwijn R; Cortot A; Viteau JM; Elewaut A; Belaiche J; Froguel E; Modigliani R
    Aliment Pharmacol Ther; 1995 Oct; 9(5):557-62. PubMed ID: 8580278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.
    Sinha A; Nightingale J; West KP; Berlanga-Acosta J; Playford RJ
    N Engl J Med; 2003 Jul; 349(4):350-7. PubMed ID: 12878742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
    Danielsson A; Hellers G; Lyrenäs E; Löfberg R; Nilsson A; Olsson O; Olsson SA; Persson T; Salde L; Naesdal J
    Scand J Gastroenterol; 1987 Oct; 22(8):987-92. PubMed ID: 3317784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
    Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
    Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.
    Spencer CM; McTavish D
    Drugs; 1995 Nov; 50(5):854-72. PubMed ID: 8586030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis.
    Nyman-Pantelidis M; Nilsson A; Wagner ZG; Borgå O
    Aliment Pharmacol Ther; 1994 Dec; 8(6):617-22. PubMed ID: 7696451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical therapy is underused in patients with ulcerative colitis.
    Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
    J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis.
    Löfberg R; Danielsson A; Suhr O; Nilsson A; Schiöler R; Nyberg A; Hultcrantz R; Kollberg B; Gillberg R; Willén R; Persson T; Salde L
    Gastroenterology; 1996 Jun; 110(6):1713-8. PubMed ID: 8964395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. The Danish Budesonide Study Group.
    Scand J Gastroenterol; 1991 Dec; 26(12):1225-30. PubMed ID: 1763292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.